Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
9.94
+0.24 (2.47%)
At close: Mar 18, 2026, 4:00 PM EDT
9.94
0.00 (0.00%)
After-hours: Mar 18, 2026, 4:10 PM EDT
Fortrea Holdings Employees
As of December 31, 2025, Fortrea Holdings had 14,300 total employees, including 13,871 full-time and 429 part-time employees. The number of employees decreased by 1,820 or -11.29% compared to the previous year.
Employees
14,300
Change
-1,820
Growth
-11.29%
Revenue / Employee
$190,448
Profits / Employee
-$68,965
Market Cap
929.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14,300 | -1,820 | -11.29% | 13,871 | 429 |
| Sep 30, 2025 | 14,500 | -1,000 | -6.45% | 14,500 | 0 |
| Jun 30, 2025 | 14,500 | -1,500 | -9.38% | 14,500 | 0 |
| Mar 31, 2025 | 15,000 | -1,000 | -6.25% | 15,000 | 0 |
| Dec 31, 2024 | 16,120 | -1,880 | -10.44% | 15,500 | 620 |
| Sep 30, 2024 | 15,500 | -3,500 | -18.42% | 15,500 | 0 |
| Jun 30, 2024 | 16,000 | -3,000 | -15.79% | 16,000 | 0 |
| Mar 31, 2024 | 16,000 | -2,000 | -11.11% | 16,000 | 0 |
| Dec 31, 2023 | 18,000 | 0 | - | 17,460 | 540 |
| Sep 30, 2023 | 19,000 | 1,000 | 5.56% | 19,000 | 0 |
| Jun 30, 2023 | 19,000 | - | - | 19,000 | 0 |
| Mar 31, 2023 | 18,000 | - | - | 17,370 | 630 |
| Dec 31, 2022 | 18,000 | - | - | 17,370 | 630 |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| KalVista Pharmaceuticals | 270 |
| Xencor | 260 |
| ARS Pharmaceuticals | 163 |
| Sana Biotechnology | 142 |
| Adlai Nortye | 123 |
| Cullinan Therapeutics | 109 |
| Janux Therapeutics | 109 |
FTRE News
- 8 days ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Fortrea Holdings Inc. (FTRE) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - GlobeNewsWire
- 4 weeks ago - Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - GlobeNewsWire
- 6 weeks ago - Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call - GlobeNewsWire
- 2 months ago - Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE - PRNewsWire
- 2 months ago - Fortrea Holdings Inc. (FTRE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference - GlobeNewsWire